Benjamin Winograd
Geen lopende functies
Profiel
Benjamin Winograd worked as an Executive Director-Clinical Oncology at Bristol Myers Squibb Co. from 1990 to 1999.
He then worked as Vice President-Global Medical Affairs & Oncology at Schering-Plough Biopharma from 2004 to 2007.
From 2007 to 2020, he worked at Celgene Corp.
as Head-Clinical R&D Therapeutic Area.
Currently, he is the Chief Medical Officer at LAVA Therapeutics NV, a position he started in 2020 and will hold until 2023.
Dr. Winograd received his graduate and doctorate degrees from Technische Universität München.
Eerdere bekende functies van Benjamin Winograd
| Bedrijven | Functie | Einde |
|---|---|---|
| LAVA THERAPEUTICS N.V. | Chief Tech/Sci/R&D Officer | 06-02-2023 |
| CELGENE | Corporate Officer/Principal | 01-01-2020 |
Schering-Plough Biopharma
 Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a private company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Corporate Officer/Principal | 01-01-2007 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-1999 |
Opleiding van Benjamin Winograd
| Technische Universität München | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| LAVA THERAPEUTICS N.V. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a private company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Commercial Services |
